A Phase II Trial of Sequential MTx and 5-FU Alternated with 4-Epidoxorubicin and Cisplatin in Advanced Gastric Cancer

B. G. Taal Department of Gastroenterology, The Netherlands Cancer Institut, Amsterdam, The Netherlands

W. W. Huinink ten Bokkel Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

G. Simonetti Department of Gastroenterology, The Netherlands Cancer Institut, Amsterdam, The Netherlands

H. Franklin Department of Gastroenterology, The Netherlands Cancer Institut, Amsterdam, The Netherlands

J. G. McVie Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

References

O'Connell M J. Current status of chemotherapy for advanced pancreatic and gastric cancer. J Clin Oncol 1985; 3: 1032–1039
PubMed Web of Science ®Google Scholar
Klein H O, Dias Wickramanayake P, Dieterle F, et al. Chemotherapieprotokoll zur Behandlung des metastasierende Magenkarzinoms. Dtsch Med Wschr 1982; 107: 1708–1712
PubMedGoogle Scholar
Cunningham D, Gilchrist N C, Forrest G J, et al. Chemotherapy in advanced gastric cancer. Cancer Treat Rep 1985; 69: 927–928
PubMedGoogle Scholar
Stoller R G, Hande K R, Jacobs S A, et al. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity. N Engl J Med 1977; 297: 630–634
PubMed Web of Science ®Google Scholar
Bareham C R, Griswold D E, Calabresi P. Synergism of methotrexate with Imuran and with 5FU and their effects on hemolysin plaqueforming cell production in mouse. Cancer Res 1974; 34: 571–575
PubMed Web of Science ®Google Scholar
Bonfante V, Villani F, Bonnadonna G. Toxic and therapeutic activity of 4-epidoxorubicin. Tumori 1982; 68: 105–111
PubMed Web of Science ®Google Scholar
Lacave A J, Izarzugaza I, Aparicio L MA, et al. Phase II clinical trial of cis-dichlorodiamine platinum in gastric cancer. Am J Clin Oncol 1983; 6: 35–38
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A Phase II Trial of Sequential MTx and 5-FU Alternated with 4-Epidoxorubicin and Cisplatin in Advanced Gastric Cancer

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A Phase II Trial of Sequential MTx and 5-FU Alternated with 4-Epidoxorubicin and Cisplatin in Advanced Gastric Cancer

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date